Cataracts Associated With Fibroblast Growth Factor Receptor Inhibitors for Cholangiocarcinoma.
Kassaye Isabell, Alyafaie Adam, Zhang Karen, Lifton Jacob, Gordan John D, Kelley Robin Kate et al.
This study found FGFR inhibitor therapy for cholangiocarcinoma is associated with cataract development or progression, even after treatment stops, highlighting the need for periodic eye exams in these patients.